WHY YOU STILL DON'T HAVE ACCESS TO MEDICAL MARIJUANA
Latest News

WHY YOU STILL DON'T HAVE ACCESS TO MEDICAL MARIJUANA

It was welcome news to Scott Treatman when the New York State Department of Health announced in December that it was expanding access to medical marijuana for those with chronic pain. Treatman’s practice in the village of Cazenovia, southeast of Syracuse, already treated a bevy of patients with conditions that ranged from lymphoma to multiple sclerosis. Most of them were referrals from other doctors who couldn’t (or often wouldn’t) prescribe the Schedule 1 drug. There were many more people, though, who weren’t covered. Now, thanks to expanded access, folks who might otherwise turn to pills or opioids such as heroin could look to weed to relieve their suffering.

It was welcome news to Scott Treatman when the New York State Department of Health announced in December that it was expanding access to medical marijuana for those with chronic pain. Treatman’s practice in the village of Cazenovia, southeast of Syracuse, already treated a bevy of patients with conditions that ranged from lymphoma to multiple sclerosis. Most of them were referrals from other doctors who couldn’t (or often wouldn’t) prescribe the Schedule 1 drug. There were many more people, though, who weren’t covered. Now, thanks to expanded access, folks who might otherwise turn to pills or opioids such as heroin could look to weed to relieve their suffering.

These days, Treatman’s phone is ringing off the hook. The expansion has been helpful, but getting patients signed up hasn’t been easy. The population he treats is older, and online registration has been arduous for his octogenarian patients, Treatman says. And while more access came as a needed salve for many ailments, it also served as a new twist on the old story of health care disparities between urban and rural communities.

Only practitioners can “certify” patients for a medical marijuana card. The five counties that comprise New York City — New York, Kings, Bronx, Richmond and Queens — have more than 400 practitioners. Drive just an hour out of the city, though, and options become sparse for the 1,000 certified patients living across 23 upstate counties.

People with chronic pain sometimes drive two and a half to three hours to get certified through his practice, Treatman says. He is one of three practitioners in Madison County, although he’s the only one to register his contact information on the state’s public database for patients. “It’s kind of an illusion [that there are not] enough docs,” he notes. Plenty of family doctors and physicians are qualified, even outside big cities such as Buffalo, Rochester and Syracuse. But it can be difficult to get an appointment, with few boasting open practices — meaning they will accept new patients solely for marijuana-based treatment — and even fewer advertising the medicinal herb in their offerings.

Marijuana is often prescribed as an alternative to painkillers, which means its availability is especially important in a state where death rates from opioid overdoses increased 144 percent between 2005 and 2014, according to a legislative report from the state comptroller. That’s one of the highest jumps in the nation.

The Empire State’s struggles to ensure access may serve as an example for others — especially after a watershed election year in 2016 that saw four states legalize weed and another four legalize it for medical purposes. A New York health department initiative to allow nurses and physician assistants to certify marijuana patients will particularly help “in many rural counties where fewer physicians are available,” a spokesperson tells OZY.

Technology may end up solving access issues for some rural patients. Treatman and other doctors like him already are making house calls via video chats. “Geography can be a barrier,” he says, but many of his patients face an even bigger one: the expense. In many cases, medical marijuana costs hundreds of dollars per month, and insurers don’t cover it because it remains a federally classified Schedule 1 drug. “These folks are desperate,” Treatman says. “They’ve been through the surgeries, the chemo, the neuroblocks; [they’ve] been through a bunch of pharmaceuticals that often did more harm than good, many of which have been covered through insurance. But they can’t buy this plant-based product — because they can’t afford it.”

Share to Facebook Share to Twitter Share to Google Plus